about modern meadow

our origins

The son of a theoretical physicist turned bioengineer, Andras Forgacs — the founder of Modern Meadow — was thinking of the world’s future in terms of biology before he even realized it.

Andras’ passion for science came from his father, Gabor Forgacs, who was a pioneer and innovator. A lifelong physicist, Gabor was one of the first to apply the frameworks of physics to understand biological phenomena such as how embryos develop and organs form. Around 2006, Gabor was pursuing some of the most interesting work of his career: developing a form of biofabrication called bioprinting. This innovation in 3D printing of human tissue led Andras and his father Gabor to partner with other co-founders to create the company Organovo (meaning “new organ”). Led by a dynamic team of forward-thinkers, Organovo was a San Diego-based pioneer in biofabrication focused on creating human tissue models that can be used to accelerate pharma drug discovery and development. The company went public in 2012 and Andras remained on its Board of Directors until 2014.

Nearly nine years ago, Andras once again started thinking about biofabrication as a way to reimagine how the world approaches materials, sustainability and consumption, and how they’re intertwined. Living in China in 2010-11, Andras saw that rapid growth in consumption — specifically in animal products such as leather and meat — can come at great cost to the environment. He began to wonder if the principles of biofabrication could be used to make these animal products without the animal. Soon, Modern Meadow (named to signify “a new field”) was born. 

Andras, Gabor and the small founding team at the newly-formed Modern Meadow began looking at the starting point for the creation of these materials: proteins. Experimenting with several different processes, and leveraging the knowledge and skill-set of a growing scientific team, Modern Meadow has been able to evolve its approach to create materials that support sustainability while balancing performance, aesthetics, and accessibility. While the technologies have evolved significantly since the beginning, the goal of achieving sustainability at scale has remained consistent.

leadership
team

andras forgacs

co-founder & ceo

Andras Forgacs, Co-Founder and CEO of Modern Meadow, is a serial entrepreneur in deep tech and life sciences. He is leading the company into a new age of biofabrication, working to transform the world of materials by unlocking the power of nature to offer new design possibilities. Andras is also co-Founder of 3D bioprinting company, Organovo. Previously he held positions with an international technology-focused venture fund, McKinsey & Co. and Citigroup. Andras is founding chairman of the international non-profit Resolution Project and was a Kauffman Fellow with the Center for Venture Education. He holds an MBA from The Wharton School and a Bachelor of Arts with honors from Harvard University. Named as a 2018 Tech Pioneer by the World Economic Forum, Modern Meadow enables new design and performance possibilities and partners with some of the world’s thought-leading brands to transform the material world and design for a healthier planet.

david williamson

chief technology officer

Dave Williamson has an extensive background at technology companies that include a variety of roles at DuPont and Kraton Polymers. Prior to joining Modern Meadow, David spent over a decade at DuPont building and leading a variety of technology organizations that included manufacturing technology, process development, long and short-term chemical and biotechnology research organizations and bioactives strategy in corporate research and development. David was most recently the Chief of Staff for the Office of the Chief Science and Technology Officer at DuPont, spending time at Kraton Polymers as a research scientist prior to that. Since joining Modern Meadow, Dave has been responsible for developing and executing a commercially focused and scale-able technology strategy based on a combination of biotechnology, chemistry, material science and engineering development. He holds a PhD in Chemistry from Virginia Polytechnic Institute and State University and a Bachelor of Science in Chemistry from Virginia Commonwealth University.

rex liu

chief financial officer

Rex is a finance and accounting leader with over 15 years of accounting & financial management experience working with and at emerging and high growth manufacturing companies. At Modern Meadow, Rex is leading the company through several successful financial partnerships as it makes its way to a commercial launch. He spent most of his professional career in Silicon Valley most recently at Tesla Motors where he was part of the team that took the company public. While there, Rex built and oversaw the controller ship team as well as implemented the financial systems to support the Model S launch from customer reservations to manufacturing and vehicle delivery. Prior to Tesla, Rex worked at Gilead Sciences, where he supported the financial growth of the company from $870million to $7billion in revenues. A CPA, he began his professional career at Ernst & Young serving life sciences, tech and entrepreneurial clients. Rex received his honors bachelor’s degree in immunology as well as an MBA from the University of Toronto.

susan schofer

vice president, commercial

Susan is a seasoned product and business development leader with over 15 years experience in the biotechnology, renewable chemicals and materials industries. Prior to joining Modern Meadow, Susan spent ten years in Silicon Valley, where she worked at Amyris to develop and commercialize innovative renewable performance materials products and before that at Symyx Technologies, developing and using automated workflows to accelerate discovery and commercialization of new catalysts and polymers. Earlier, Susan was a management consultant with Mitchell Madison Group. For Modern Meadow, Susan has put in place multiple collaboration agreements with leading luxury and performance brand partners, securing the company as a leading innovator in the advanced materials space. Susan received her bachelor’s degree in chemistry from Brown University and her Ph.D. in chemistry from Caltech, and she was a National Science Foundation International Postdoctoral Fellow at Stockholm and Uppsala Universities.

board of directors

anna bakst

board chair

Anna Bakst has over 25 years of experience managing and cultivating businesses for American fashion houses. She recently served as Brand President and CEO of Kate Spade. Until January 2017, Anna was Group President at Michael Kors.  From 2003, Anna drove the expansive launch and growth of Michael Kors Accessories and Footwear businesses – leading to Wall Street’s biggest public offering in fashion. In her role, Anna led the global design, production, and merchandising teams as well as oversaw domestic wholesale distribution.  Prior to Michael Kors, Anna had a 12-year career at Donna Karan International where she held various positions including President of Accessories and Footwear. She received an MBA from Stanford University and a BS in Industrial Engineering from Purdue University. Anna is also an Associate Professor at Pratt Institute's Design Management Program.

bart swanson

Bart Swanson is currently an advisor to Horizon Ventures, a venture capital firm based in Hong Kong with a focus on disruptive technologies. Mr. Swanson is on the boards of Zoom Video Communications Inc., Impossible Foods, Sentient Technologies, Benevolent AI, Hola Networks, Leo Labs Inc, and several other technology companies in Europe, Israel, and the US. Bart was previously a director at Onavo, DeepMind, Bitstrips, Crosswise.com, Viv and from 2015-17 a non-executive board member at MTG AB. Bart received an MBA from The Wharton School and an MA in International Studies from the University of Pennsylvania. He was a Fellow at the Lauder Institute and has a BA in History from the University of Southern California.

david shaw

David Evans Shaw is Managing Partner of Black Point Group, with wide-ranging interests in technology companies and public service. His business creation, leadership, investment and board experience includes IDEXX Laboratories, Ikaria Pharmaceuticals, Itaconix, Skinetics, Cyteir, Cytyc, Physion, Venrock Associates, MyTaskIt, New Mountain Capital, Polaris Venture Partners, the film Second Century Stewardship, and others. He has also served as a strategy consultant to consumer products, food and agribusiness companies.

dennis fenton

Dr. Fenton brings more than forty years of experience in biopharmaceutical drug development and commercialization to this position. During a 25-year tenure at Amgen, he served as executive vice president of operations and held numerous additional executive leadership roles in operations, process development, sales, marketing, research, engineering and manufacturing. Since retiring from Amgen in 2008, Dr. Fenton has served as an independent biotechnology consultant and serves on several public and private company boards including Portola Pharmaceuticals, Pfenex, Sienna Biopharmaceuticals, and Omniox. Dr. Fenton previously served on the boards of directors of Kythera, Amira, Hospira, Dendreon Corp., Xenoport and Genzyme Corporation. He is also a member of the board of trustees of the Keck Graduate Institute. Dr. Fenton received a Bachelor of Science in Biology from Manhattan College and a Ph.D. in Microbiology from Rutgers University.

gabor forgacs

Gabor is a theoretical physicist turned bioengineer, innovator and entrepreneur. A pioneer in building living structures using bioprinting, Gabor is the scientific founder of Organovo and Modern Meadow. The technologies he has developed have been applied to drug development and testing and tissue engineering of biomaterials. He is the George H. Vineyard Professor Emeritus of Biological Physics at the University of Missouri-Columbia and Scientific Director of the Shipley Centre for Innovation at Clarkson University. He was trained as a physicist at the Roland Eotvos University, Budapest, Hungary. He also has a degree in biology. Gabor has been recognized by numerous awards, in particular, he was named as one of the "100 most innovative people in business in 2010" by FastCompany.

doug muzyka

Douglas Muzyka was Senior Vice President and Chief Science and Technology Officer of DuPont. He joined the company in 1985 as a research scientist and held a variety of research and research management roles in North America through 1994. Dr. Muzyka was named director of Technology and New Business Development for DuPont Nylon, Asia Pacific, in 1994 and relocated to Hong Kong. From 1994 to 1998 he participated in many plant start-ups and new venture developments throughout Asia Pacific. Dr. Muzyka has served on advisory boards for universities in Singapore and Canada, as well as on boards of Chambers of Commerce, industry associations and business councils on sustainable development in Canada, Mexico and China. Mr. Muzyka was born in Canada and graduated as class valedictorian from the University of Western Ontario with bachelor, master and doctorate degrees in chemical engineering. He completed additional research for his doctorate at the Université de Technologie de Compiègne in France and worked as a researcher in the coal industry in France prior to joining DuPont.

andras forgacs

Andras Forgacs, Co-Founder and CEO of Modern Meadow, is a serial entrepreneur in deep tech and life sciences. He is leading the company into a new age of biofabrication, working to transform the world of materials by unlocking the power of nature to offer new design possibilities. Andras is also co-Founder of 3D bioprinting company, Organovo. Previously he held positions with an international technology-focused venture fund, McKinsey & Co. and Citigroup. Andras is founding chairman of the international non-profit Resolution Project and was a Kauffman Fellow with the Center for Venture Education. He holds an MBA from The Wharton School and a Bachelor of Arts with honors from Harvard University. Named as a 2018 Tech Pioneer by the World Economic Forum, Modern Meadow enables new design and performance possibilities and partners with some of the world’s thought-leading brands to transform the material world and design for a healthier planet.

select investors

careers

It takes a team of innovators to lead us into a new material age. We’re looking for the forward-thinkers, the highly motivated, and the all-around passionate. If you can embrace a challenge, take ownership, and know how to have fun, we want to hear from you. At Modern Meadow, we thrive on diversity, embrace uncertainty and value every opinion. Be part of a dynamic group changing the future of biofabrication, all in a fast-paced, inspiring environment.

If you find a position that matches your skill set, and you think you’re a good match for Modern Meadow, fill out an online application. Attach your resume, cover letter and any other relevant info to help us understand why you’re the right person for the job.

Once you submit your application, you will receive a confirmation email. We will carefully review your application and respond personally to applicants that best match the qualifications for the open positions. We consider all qualified applicants for employment without discrimination on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability or any other factors prohibited by law.

what can we grow together?

the team

andras forgacs

co-founder & ceo

Andras Forgacs, Co-Founder and CEO of Modern Meadow, is a serial entrepreneur in deep tech and life sciences. He is leading the company into a new age of biofabrication, working to transform the world of materials by unlocking the power of nature to offer new design possibilities. Andras is also co-Founder of 3D bioprinting company, Organovo. Previously he held positions with an international technology-focused venture fund, McKinsey & Co. and Citigroup. Andras is founding chairman of the international non-profit Resolution Project and was a Kauffman Fellow with the Center for Venture Education. He holds an MBA from The Wharton School and a Bachelor of Arts with honors from Harvard University. Named as a 2018 Tech Pioneer by the World Economic Forum, Modern Meadow enables new design and performance possibilities and partners with some of the world’s thought-leading brands to transform the material world and design for a healthier planet.

david williamson

chief technology officer

Dave Williamson has an extensive background at technology companies that include a variety of roles at DuPont and Kraton Polymers. Prior to joining Modern Meadow, David spent over a decade at DuPont building and leading a variety of technology organizations that included manufacturing technology, process development, long and short-term chemical and biotechnology research organizations and bioactives strategy in corporate research and development. David was most recently the Chief of Staff for the Office of the Chief Science and Technology Officer at DuPont, spending time at Kraton Polymers as a research scientist prior to that. Since joining Modern Meadow, Dave has been responsible for developing and executing a commercially focused and scale-able technology strategy based on a combination of biotechnology, chemistry, material science and engineering development. He holds a PhD in Chemistry from Virginia Polytechnic Institute and State University and a Bachelor of Science in Chemistry from Virginia Commonwealth University.

rex liu

chief financial officer

Rex is a finance and accounting leader with over 15 years of accounting & financial management experience working with and at emerging and high growth manufacturing companies. At Modern Meadow, Rex is leading the company through several successful financial partnerships as it makes its way to a commercial launch. He spent most of his professional career in Silicon Valley most recently at Tesla Motors where he was part of the team that took the company public. While there, Rex built and oversaw the controller ship team as well as implemented the financial systems to support the Model S launch from customer reservations to manufacturing and vehicle delivery. Prior to Tesla, Rex worked at Gilead Sciences, where he supported the financial growth of the company from $870million to $7billion in revenues. A CPA, he began his professional career at Ernst & Young serving life sciences, tech and entrepreneurial clients. Rex received his honors bachelor’s degree in immunology as well as an MBA from the University of Toronto.

susan schofer

vice president, commercial

Susan is a seasoned product and business development leader with over 15 years experience in the biotechnology, renewable chemicals and materials industries. Prior to joining Modern Meadow, Susan spent ten years in Silicon Valley, where she worked at Amyris to develop and commercialize innovative renewable performance materials products and before that at Symyx Technologies, developing and using automated workflows to accelerate discovery and commercialization of new catalysts and polymers. Earlier, Susan was a management consultant with Mitchell Madison Group. For Modern Meadow, Susan has put in place multiple collaboration agreements with leading luxury and performance brand partners, securing the company as a leading innovator in the advanced materials space. Susan received her bachelor’s degree in chemistry from Brown University and her Ph.D. in chemistry from Caltech, and she was a National Science Foundation International Postdoctoral Fellow at Stockholm and Uppsala Universities.

board of directors

anna bakst

board chair

Anna Bakst has over 25 years of experience managing and cultivating businesses for American fashion houses. She recently served as Brand President and CEO of Kate Spade. Until January 2017, Anna was Group President at Michael Kors. From 2003, Anna drove the expansive launch and growth of Michael Kors Accessories and Footwear businesses – leading to Wall Street’s biggest public offering in fashion. In her role, Anna led the global design, production, and merchandising teams as well as oversaw domestic wholesale distribution.  Prior to Michael Kors, Anna had a 12-year career at Donna Karan International where she held various positions including President of Accessories and Footwear. She received an MBA from Stanford University and a BS in Industrial Engineering from Purdue University. Anna is also an Associate Professor at Pratt Institute's Design Management Program.

andras forgacs

Andras Forgacs, Co-Founder and CEO of Modern Meadow, is a serial entrepreneur in deep tech and life sciences. He is leading the company into a new age of biofabrication, working to transform the world of materials by unlocking the power of nature to offer new design possibilities. Andras is also co-Founder of 3D bioprinting company, Organovo. Previously he held positions with an international technology-focused venture fund, McKinsey & Co. and Citigroup. Andras is founding chairman of the international non-profit Resolution Project and was a Kauffman Fellow with the Center for Venture Education. He holds an MBA from The Wharton School and a Bachelor of Arts with honors from Harvard University. Named as a 2018 Tech Pioneer by the World Economic Forum, Modern Meadow enables new design and performance possibilities and partners with some of the world’s thought-leading brands to transform the material world and design for a healthier planet.

dennis fenton

Dr. Fenton brings more than forty years of experience in biopharmaceutical drug development and commercialization to this position. During a 25-year tenure at Amgen, he served as executive vice president of operations and held numerous additional executive leadership roles in operations, process development, sales, marketing, research, engineering and manufacturing. Since retiring from Amgen in 2008, Dr. Fenton has served as an independent biotechnology consultant and serves on several public and private company boards including Portola Pharmaceuticals, Pfenex, Sienna Biopharmaceuticals, and Omniox. Dr. Fenton previously served on the boards of directors of Kythera, Amira, Hospira, Dendreon Corp., Xenoport and Genzyme Corporation. He is also a member of the board of trustees of the Keck Graduate Institute. Dr. Fenton received a Bachelor of Science in Biology from Manhattan College and a Ph.D. in Microbiology from Rutgers University.

gabor forgacs

Gabor is a theoretical physicist turned bioengineer, innovator and entrepreneur. A pioneer in building living structures using bioprinting, Gabor is the scientific founder of Organovo and Modern Meadow. The technologies he has developed have been applied to drug development and testing and tissue engineering of biomaterials. He is the George H. Vineyard Professor Emeritus of Biological Physics at the University of Missouri-Columbia and Scientific Director of the Shipley Centre for Innovation at Clarkson University. He was trained as a physicist at the Roland Eotvos University, Budapest, Hungary. He also has a degree in biology. Gabor has been recognized by numerous awards, in particular, he was named as one of the "100 most innovative people in business in 2010" by FastCompany.

doug muzyka

Douglas Muzyka was Senior Vice President and Chief Science and Technology Officer of DuPont. He joined the company in 1985 as a research scientist and held a variety of research and research management roles in North America through 1994. Dr. Muzyka was named director of Technology and New Business Development for DuPont Nylon, Asia Pacific, in 1994 and relocated to Hong Kong. From 1994 to 1998 he participated in many plant start-ups and new venture developments throughout Asia Pacific. Dr. Muzyka has served on advisory boards for universities in Singapore and Canada, as well as on boards of Chambers of Commerce, industry associations and business councils on sustainable development in Canada, Mexico and China. Mr. Muzyka was born in Canada and graduated as class valedictorian from the University of Western Ontario with bachelor, master and doctorate degrees in chemical engineering. He completed additional research for his doctorate at the Université de Technologie de Compiègne in France and worked as a researcher in the coal industry in France prior to joining DuPont.

david shaw

David Evans Shaw is Managing Partner of Black Point Group, with wide-ranging interests in technology companies and public service. His business creation, leadership, investment and board experience includes IDEXX Laboratories, Ikaria Pharmaceuticals, Itaconix, Skinetics, Cyteir, Cytyc, Physion, Venrock Associates, MyTaskIt, New Mountain Capital, Polaris Venture Partners, the film Second Century Stewardship, and others. He has also served as a strategy consultant to consumer products, food and agribusiness companies.

bart swanson

Bart Swanson is currently an advisor to Horizon Ventures, a venture capital firm based in Hong Kong with a focus on disruptive technologies. Mr. Swanson is on the boards of Zoom Video Communications Inc., Impossible Foods, Sentient Technologies, Benevolent AI, Hola Networks, Leo Labs Inc, and several other technology companies in Europe, Israel, and the US. Bart was previously a director at Onavo, DeepMind, Bitstrips, Crosswise.com, Viv and from 2015-17 a non-executive board member at MTG AB. Bart received an MBA from The Wharton School and an MA in International Studies from the University of Pennsylvania. He was a Fellow at the Lauder Institute and has a BA in History from the University of Southern California.